INTRODUCTION
This study analyzes the US market for biochip products and services. Products
examined include DNA, laboratory and protein chips (microarrays); production,
detection, and sample preparation and hybridization instruments; reagents and
other consumables; and software. Services covered consist of licensing, contract
research, consulting, technical support and maintenance. The biochip market is
also analyzed in terms of major applications (drug discovery, life science
research, diagnostics testing, forensic medicine, health management,
agriculture, defense systems, and environment and industrial testing) and key
end users (pharmaceutical companies, biotechnology companies, colleges and
universities, government agencies, medical providers and other customer groups).
Unless otherwise indicated, the statistics appearing in this study correlate
to US demand for biochip products and services. The term 電emand・
is equivalent to the terms 殿pparent consumption・and 都ales・(at
the wholesale level). Historical (1998, 2000, 2003) data and forecasts to 2008
and 2013 are presented for biochip products and services by type, applications
and market. Statistics are also provided for key market indicators, including
gross domestic product, population by age group, medical conditions, national
health expenditures, medical providers, patient procedures, pharmaceutical
shipments, diagnostic product shipments and medical research products. Gross
domestic product and population statistics were taken from The Freedonia Group
Incorporated Consensus Forecasts dated August 2004.
View Cart
